24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
40.86% |
|
PEPTIDOMIMETIC CD40L BINDING |
32.26% |
|
ATSTP10 TRANSPORT SIMULATION |
16.13% |
|
ENZYME DYNAMICS |
10.75% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
56.65% |
|
PEPTIDOMIMETIC CD40L BINDING |
36.78% |
|
ATSTP10 SUCROSE TRANSPORT |
2.46% |
|
ATSTP10 TRANSPORT SIMULATION |
2.46% |
|
ENZYME DYNAMICS |
1.64% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
35.98% |
|
CANCER |
20.32% |
|
PEPTIDOMIMETIC CD40L BINDING |
16.81% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
12.02% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
10.46% |
|
ATSTP10 SUCROSE TRANSPORT |
1.65% |
|
ALZHEIMERS |
1.58% |
|
ATSTP10 TRANSPORT SIMULATION |
.67% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.33% |
|
MEMBRANE TRANSPORT |
.19% |